Colombia is considering a decree that could transform the landscape of scientific research on medical cannabis by allowing universities and entities recognized by Colciencias to access exclusive licenses for non-commercial academic studies. Colombian regulations currently allow for the cultivation, production, and processing of cannabis for medical purposes, but restrict independent research at the university level.
With the possible issuance of the decree, a regulated space would be opened for academic institutions and research centers to develop specific, non-profit projects aimed at generating scientific knowledge about the efficacy and safety of treatments derived from this plant.
The Colombian Association for the Study of Pain (ACED) estimates that 70% of Colombians, or 42 million people, have experienced chronic pain at some point in their lives .
This condition affects work capacity, physical activity, rest, and social and family relationships. Currently, patients with epilepsy, multiple sclerosis, anxiety disorders, insomnia, and chronic pain can access cannabis-derived medications with a medical prescription through their health benefits plan.
Read more at Infobae
